Dulaglutide vs Orforglipron

Molecule comparison

Last updated 2026-05-28 15:46 UTC

Dulaglutide (brand name Trulicity) is an injectable GLP-1 drug already approved by the FDA to treat type 2 diabetes and reduce cardiovascular risk. Orforglipron is an experimental oral (pill) GLP-1 drug still in development, with no FDA approvals yet for any use.

AI summary of the sources below.

	Dulaglutide	Orforglipron
Mechanism	GLP-1 receptor agonist	Oral non-peptide GLP-1 receptor agonist
Status	Approved	Pipeline
Branded products	trulicity	—

Compare full details on the Dulaglutide and Orforglipron pages.